Cancer Research TCM Europe  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenzie, P. P.
Right arrow Articles by Harris, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenzie, P. P.
Right arrow Articles by Harris, L. C.
[Cancer Research 63, 3840-3844, July 1, 2003]
© 2003 American Association for Cancer Research


Tumor Biology

p21Waf1/Cip1 Dysfunction in Neuroblastoma

A Novel Mechanism of Attenuating G0-G1 Cell Cycle Arrest1

Pamela P. McKenzie, Mary K. Danks, Richard W. Kriwacki and Linda C. Harris2

Departments of Molecular Pharmacology [P. P. M., M. K. D., L. C. H.] and Structural Biology [R. W. K.], St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

In normal cells in which DNA has been damaged, p53 induces the expression of p21Waf1/Cip1; p21, in turn, binds to cyclin-dependent kinase 2 (cdk2) and inhibits its function. Inhibition of cdk2 results in cell cycle arrest in G0-G1. Although p53 is transcriptionally active and induces p21 expression in neuroblastoma (NB) cells, the G0-G1 checkpoint is attenuated. Here we report that the mechanism that mediates this defect in NB cells is the inability of p21 to bind to, or inhibit the activity of cdk2. However, when recombinant p21 protein was added to NB cell extracts in vitro, the protein inhibited the activity of cdk2. This finding suggests that endogenous p21 protein in NB cells is inactive and may be bound either to a protein complex or in a conformation that precludes its binding to cdk2. The dysfunction of p21 in NB cells represents a novel mechanism by which the G0-G1 cell cycle checkpoint can be inactivated. This mechanism may be important in regulating the growth of NB and potentially other types of tumors. Cdk inhibitors currently being developed for clinical use may be useful therapy for tumors such as NB in which endogenous cdk inhibitors are defective.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. Jarviluoma, E. S. Child, G. Sarek, P. Sirimongkolkasem, G. Peters, P. M. Ojala, and D. J. Mann
Phosphorylation of the Cyclin-Dependent Kinase Inhibitor p21Cip1 on Serine 130 Is Essential for Viral Cyclin-Mediated Bypass of a p21Cip1-Imposed G1 Arrest
Mol. Cell. Biol., March 15, 2006; 26(6): 2430 - 2440.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Mei, Z. Mao, X. Shen, W. Wang, B. Dai, B. Tang, Y. Wu, Y. Cao, S. Zhang, H. Zhao, et al.
Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease
Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2368 - 2375.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. J. Rorie and B. E. Weissman
The Ews/Fli-1 Fusion Gene Changes the Status of p53 in Neuroblastoma Tumor Cell Lines
Cancer Res., October 15, 2004; 64(20): 7288 - 7295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.